Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Lucid Group Secures $1B Revolving Credit Facility

Lucid Group Inc (NASDAQ:LCID) has entered into a credit agreement with a syndicate of banks to provide a secured asset-based revolving credit facility with an initial committed amount of up to $1.0 billion. The facility also provides for uncommitted incremental revolving commitments of up to an additional $500 million. The ABL Credit Facility has…

Benzinga

Ominous Death Cross Forms On O'Reilly Automotive's Chart

If history is any guide, there may be trouble ahead for shares of O'Reilly Automotive (NASDAQ:ORLY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Bitcoin Plummets But Is There More Downside Ahead?

Despite the Nasdaq bouncing 0.21% yesterday and both the S&P 500 and Nasdaq futures showing gains this morning, Bitcoin (CRYPTO: BTC) continues to plummet. What are the factors contributing to this extreme sell off?

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Short Volatility Alert: Adverum Biotechnologies, Inc.

On Tuesday, shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) experienced volatile short activity. After the activity, the stock price went down -2.74% to $0.9259. The overall sentiment for ADVM has been Bearish.

Benzinga

Short Volatility Alert: Eagle Pharmaceuticals, Inc.

On Tuesday, shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) experienced volatile short activity. After the activity, the stock price went up +2.39% to $43.35. The overall sentiment for EGRX has been Bearish.

Benzinga

5 Value Stocks In The Industrials Sector

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $800 Today

Microsoft (NASDAQ:MSFT) has outperformed the market over the past 10 years by 12.51% on an annualized basis producing an average annual return of 23.32%. Currently, Microsoft has a market capitalization of $1.87 trillion.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why Sidus Space Shares Are Skyrocketing Today

Sidus Space, Inc. (NASDAQ:SIDU), a Space-as-a-Service company, is now a part of the Collins Aerospace team, which was awarded NASA's Exploration Extravehicular Activity (xEVAS) services contract. Recently, NASA awarded the contract to Collins Aerospace and Axiom Space. Collins Aerospace is a unit of Raytheon Technologies Corp (NYSE:RTX). The xEVAS contract has a potential value of $3.5 billion…

Benzinga

Research: Tesla To Be Overtaken By This Legacy Automaker As Top EV Maker By 2024

Germany’s Volkswagen Group (OTC: VWAGY) could grab the top electric vehicle maker crown from Tesla Inc (NASDAQ: TSLA), according to a research report by Bloomberg Intelligence.

Benzinga

6 Analysts Have This to Say About Indie Semiconductor

Analysts have provided the following ratings for Indie Semiconductor (NASDAQ:INDI) within the last quarter:

Benzinga

Beyond Air Earnings Preview

Beyond Air (NASDAQ:XAIR) is set to give its latest quarterly earnings report on Thursday, 2022-06-16. Here's what investors need to know before the announcement. Analysts estimate that Beyond Air will report an earnings per share (EPS) of $-0.27.

Benzinga

What 4 Analyst Ratings Have To Say About Pinnacle Finl Partners

Pinnacle Finl Partners (NASDAQ:PNFP) has observed the following analyst ratings within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2022

Upgrades

Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $3,600 Today

Moderna (NASDAQ:MRNA) has outperformed the market over the past 10 years by 32.14% on an annualized basis producing an average annual return of 42.94%. Currently, Moderna has a market capitalization of $49.53 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Mid-Morning Market Update: Markets Open Higher; US Retail Sales Drop In May

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

Benzinga

springbig Completes Merger With Tuatara Capital, Starts Trading On NASDAQ

springbig and Tuatara Capital Acquisition Corporation have completed their business combination.

Benzinga

Minerva Surgical Earnings Perspective: Return On Capital Employed

Minerva Surgical (NASDAQ:UTRS) brought in sales totaling $10.94 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 201.08%, resulting in a loss of $10.93 million.

Benzinga

Exagen's Return On Capital Employed Overview

Exagen (NASDAQ:XGN) brought in sales totaling $10.39 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 45.64%, resulting in a loss of $10.27 million.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cue Health Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Cue Health (NASDAQ:HLTH) posted Q1 earnings of $2.80 million, an increase from Q4 of 91.81%. Sales dropped to $179.41 million, a 6.8% decrease between quarters.

Benzinga

Societal CDMO's Return On Capital Employed Overview

Benzinga Pro data, Societal CDMO (NASDAQ:SCTL) reported Q1 sales of $21.20 million. Earnings fell to a loss of $4.26 million, resulting in a 80.91% decrease from last quarter.

Benzinga

Tango Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Tango Therapeutics (NASDAQ:TNGX) reported Q1 sales of $5.76 million. Earnings fell to a loss of $25.21 million, resulting in a 14.34% decrease from last quarter.

Benzinga

RAPT Therapeutics Earnings Perspective: Return On Capital Employed

Benzinga Pro data, RAPT Therapeutics (NASDAQ:RAPT) reported Q1 sales of $641.00 thousand. Earnings fell to a loss of $20.47 million, resulting in a 14.16% decrease from last quarter.

Benzinga

Looking Into Priority Tech Holdings's Return On Capital Employed

Priority Tech Holdings (NASDAQ:PRTH) brought in sales totaling $153.24 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 102.36%, resulting in a loss of $333.00 thousand.

Benzinga

Summit Wireless's Return On Capital Employed Overview

Summit Wireless (NASDAQ:WISA) brought in sales totaling $566.00 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 27.21%, resulting in a loss of $3.90 million.

Benzinga

Arhaus's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, Arhaus (NASDAQ:ARHS) earned $16.06 million, a 152.8% increase from the preceding quarter. Arhaus also posted a total of $246.30 million in sales, a 3.39% increase since Q4.

1 … 380 381 382 383

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.